| Literature DB >> 28222631 |
Ayça Sultan Şahin1, Necmiye Ay1, Nuri Alper Şahbaz2, Mehlika Kocabaş Akay3, Yavuz Demiraran1, Abdurrahim Derbent1.
Abstract
Objective To evaluate the effects of an ultrasound-guided transverse abdominis plane (US-TAP) block used for postoperative pain relief by comparing the efficacy of two different volumes/concentrations of the local anaesthetic bupivacaine in patients undergoing laparoscopic cholecystectomies. Methods This randomized study enrolled patients undergoing laparoscopic cholecystectomies. They were randomized to two groups: group A received a 20 ml US-TAP block (50 mg bupivacaine +10 ml saline solution) and group B received a 30 ml US-TAP block (50 mg bupivacaine + 20 ml saline solution). The intraoperative consumption of remifentanil, the requirement for postoperative rescue analgesics, patient satisfaction scores, postoperative complications, and postoperative pain as measured by a visual analogue scale at 20 min, 12 h, and 24 h were recorded. Results A total of 60 patients enrolled in the study. There were no differences between the two groups with respect to demographic characteristics, duration of anaesthesia and patient satisfaction scores. The intraoperative consumption of remifentanil, postoperative VAS scores (20 min, 12 h and 24 h) and the requirement for postoperative analgesics were all significantly lower in group B who received a larger volume but a lower concentration of local anaesthetic solution compared with group A. Conclusion A US-TAP block can form part of a balanced postoperative analgesic regimen following laparoscopic cholecystectomy.Entities:
Keywords: Ultrasound-guided; laparoscopic cholecystectomy; postoperative pain; transverse abdominis plane block
Mesh:
Substances:
Year: 2017 PMID: 28222631 PMCID: PMC5536595 DOI: 10.1177/0300060516682883
Source DB: PubMed Journal: J Int Med Res ISSN: 0300-0605 Impact factor: 1.671
Figure 1.Flow diagram showing patient numbers are various stages of this randomized comparative study of the effects on pain relief of two different volumes and concentrations of the local anaesthetic bupivacaine administered via ultrasound-guided transversus abdominis plane block in patients undergoing laparoscopic cholecystectomies.
Baseline clinical, demographic and surgical characteristics of patients undergoing laparoscopic cholecystectomies for which the local anaesthetic bupivacaine was administered via ultrasound-guided transversus abdominis plane block.
| Characteristic | Group A | Group B |
|---|---|---|
| Age, years | 47.2 ± 13.0 | 46.5 ± 11.5 |
| Sex, female/male | 15/15 | 12/18 |
| Body mass index, kg/m2 | 25.0 ± 1.9 | 25.8 ± 2.1 |
| ASA physical status, I/II | 9/21 | 14/16 |
| Duration of anaesthesia, min | 65.2 ± 18.6 | 74.5 ± 20.6 |
| Duration of surgery, min | 51.7 ± 17.2 | 62.5 ± 20.8 |
Data are presented mean ± SD or n of patients.
P = 0.036 compared with group A; Mann–Whitney U-test.
ASA, American Society of Anesthesiologists.
Figure 2.Haemodynamic parameters measured in patients undergoing laparoscopic cholecystectomies for which the local anaesthetic bupivacaine was administered via ultrasound-guided transversus abdominis plane block. (a) Median of mean arterial pressure; (b) median peripheral blood oxygen saturation (SpO2); and (c) median heart rate. Vertical bars show the 25th and 75th percentiles. The colour version of this figure is available at: http://imr.sagepub.com.
Intraoperative consumption of remifentanil during surgery and visual analogue scale (VAS) pain scores for patients undergoing laparoscopic cholecystectomies for which the local anaesthetic bupivacaine was administered via ultrasound-guided transversus abdominis plane block.
| Group A | Group B | Statistical significance[ | |
|---|---|---|---|
| Remifentanil dose, µg | 300 (150–500) | 250 (150–500) | |
| VAS pain score | |||
| 20 min | 2.0 (0–8) | 2.0 (0–4) | |
| 12 h | 2.5 (0–7) | 1.0 (0–4) | |
| 24 h | 3.0 (1–7) | 1.0 (0–4) |
Data are presented as median (range).
Group A compared with group B; Mann–Whitney U-test.